ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.240
-0.015 (-0.67%)
At close: Aug 12, 2025, 4:00 PM
2.270
+0.030 (1.34%)
Pre-market: Aug 13, 2025, 7:26 AM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $655.65 million as of August 13, 2025. Its market cap has increased by 128.54% in one year.
Market Cap
655.65M
Enterprise Value
365.34M
1-Year Change
128.54%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $655.65M, an increase of 1,197.04%. That is a compound annual growth rate of 86.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 300.85M | 39.11% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| Novartis AG | 230.64B |
| AstraZeneca | 229.47B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |